Status:
COMPLETED
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
Lead Sponsor:
Merck KGaA, Darmstadt, Germany
Conditions:
Hypothyroidism
Eligibility:
All Genders
35-60 years
Brief Summary
This observational survey with prospective and/or retrospective follow-up is designed to study practices for the initial treatment of hypothyroidism in France without modifying subject treatment.
Detailed Description
Thyroid disorder can be central, caused by a deficiency in thyroid stimulating hormone (TSH) production; or peripheral, caused by the decrease in the plasma concentration of thyroid hormones, more spe...
Eligibility Criteria
Inclusion
- Recently diagnosed hypothyroid subject (either during the inclusion period, or within the 6 previous months) for whom, data related to the diagnosis is available if the diagnosis was not carried out initially by the investigating doctor
- Subject, who has given his/her oral consent for participation
Exclusion
- Subject included in clinical trial or having participated in a clinical trial during the last 3 months
- Subject presenting a major and objectifiable risk of not being able to follow-up until the next TSH level (moving, problems encountered during another study, pathology affecting the vital prognosis in the short-term)
- All contraindications to Lévothyrox
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
1285 Patients enrolled
Trial Details
Trial ID
NCT01197183
Start Date
October 1 2008
End Date
September 1 2009
Last Update
February 4 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Merck Lipha Santé Laboratories
Saint-Romain, Lyon, France, 69008